ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 405 out of 2588

$409K Total Retail Price of All Prescriptions

Rank: 665 out of 2588

269 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 269 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,224 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 488 434 1 1
LISINOPRIL 478 453 2 3
FUROSEMIDE 327 286 3 5
ALLOPURINOL 323 308 4 33
AMLODIPINE BESYLATE 283 253 5 4
METOPROLOL SUCCINATE 241 208 6 12
KLOR-CON 10 239 201 7 75
HYDROCHLOROTHIAZIDE 236 199 8 13
METOPROLOL TARTRATE 233 211 9 9
LOSARTAN POTASSIUM 218 181 10 17
GLIPIZIDE ER 197 170 11 73
GABAPENTIN 195 180 12 18
HYDROCODONE-ACETAMINOPHEN 152 105 S3 13 7
METFORMIN HCL 152 126 13 8
ALENDRONATE SODIUM 141 128 15 21
ATENOLOL 129 122 16 14
OMEPRAZOLE 125 107 17 6
POTASSIUM CHLORIDE 119 106 18 15
LEVOTHYROXINE SODIUM 118 117 19 2
KLOR-CON M10 113 96 20 139
WARFARIN SODIUM 108 108 21 10
VERAPAMIL ER 103 103 22 102
RANITIDINE HCL 102 85 23 37
ATORVASTATIN CALCIUM 101 96 24 11
PRAVASTATIN SODIUM 100 93 25 16
FELODIPINE ER 99 99 26 108
LOVASTATIN 98 88 27 34
TRAMADOL HCL 98 94 27 19
CARVEDILOL 96 84 29 20
JANUVIA 93 90 30 60
FAMOTIDINE 87 87 31 36
PANTOPRAZOLE SODIUM 87 67 31 28
CLOPIDOGREL 82 68 33 30
DILTIAZEM 24HR ER 80 60 34 166
DIOVAN 77 77 35 29
KLOR-CON M20 76 76 36 52
DOXAZOSIN MESYLATE 74 74 37 96
GLIPIZIDE 74 74 37 44
ENALAPRIL MALEATE 72 64 39 31
TRIAMTERENE-HCTZ 72 59 39 46
HYDRALAZINE HCL 65 65 41 53
NIFEDIAC CC 59 48 42 253
SERTRALINE HCL 57 54 43 26
CRESTOR 57 34 43 25
DILTIAZEM ER 56 49 45 150
ACETAMINOPHEN-CODEINE 53 47 S3 46 80
KETOCONAZOLE 51 44 47 195
METHYLDOPA 50 50 R 48 425
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.